These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9572232)
61. [Results of long-term follow-up in treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enantone-Gyn monthly depot)]. Regidor PA; Schindler AE; Bühler K; Gerhard I; Kimmig R; Meinen K; Hoffmann G; Lübben G; Kienle E Zentralbl Gynakol; 1996; 118(5):283-90. PubMed ID: 8701625 [TBL] [Abstract][Full Text] [Related]
62. One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial. Fernandez H; Lucas C; Hédon B; Meyer JL; Mayenga JM; Roux C Hum Reprod; 2004 Jun; 19(6):1465-71. PubMed ID: 15105403 [TBL] [Abstract][Full Text] [Related]
63. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement. Williams SR; Frenchek B; Speroff T; Speroff L Am J Obstet Gynecol; 1990 Feb; 162(2):438-46. PubMed ID: 2309827 [TBL] [Abstract][Full Text] [Related]
64. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Mezrow G; Shoupe D; Spicer D; Lobo R; Leung B; Pike M Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137 [TBL] [Abstract][Full Text] [Related]
65. The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study. Fraser DI; Parsons A; Whitehead MI; Wordsworth J; Stuart G; Pryse-Davies J Fertil Steril; 1990 Mar; 53(3):460-8. PubMed ID: 2407564 [TBL] [Abstract][Full Text] [Related]
67. Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis. Hillard TC; Siddle NC; Whitehead MI; Fraser DI; Pryse-Davies J Am J Obstet Gynecol; 1992 Jul; 167(1):1-7. PubMed ID: 1442905 [TBL] [Abstract][Full Text] [Related]
68. Hepatic Adenomas in Adolescents and Young Women with Endometriosis Treated with Norethindrone Acetate. Brady PC; Missmer SA; Laufer MR J Pediatr Adolesc Gynecol; 2017 Jun; 30(3):422-424. PubMed ID: 28024920 [TBL] [Abstract][Full Text] [Related]
69. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis]. Song JH; Lu H; Zhang J; Li B Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923 [TBL] [Abstract][Full Text] [Related]
70. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate. Odmark IS; Jonsson B; Bäckström T Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178 [TBL] [Abstract][Full Text] [Related]
71. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Ailawadi RK; Jobanputra S; Kataria M; Gurates B; Bulun SE Fertil Steril; 2004 Feb; 81(2):290-6. PubMed ID: 14967362 [TBL] [Abstract][Full Text] [Related]
72. Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique Scala C; Leone Roberti Maggiore U; Barra F; Venturini PL; Ferrero S Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():89-94. PubMed ID: 29408753 [TBL] [Abstract][Full Text] [Related]
73. [Parenchymal thoracic endometriosis--diagnosis and therapy]. Schwack M; Montag M; Schindler AE Zentralbl Gynakol; 1997; 119(4):181-5. PubMed ID: 9206925 [TBL] [Abstract][Full Text] [Related]
74. Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study. Friedman AJ Fertil Steril; 1989 Mar; 51(3):526-8. PubMed ID: 2537769 [TBL] [Abstract][Full Text] [Related]
75. Hormonal treatment of bilateral proximal tubal obstruction. Muneyyirci-Delale O; Karacan M Int J Fertil Womens Med; 1999; 44(4):204-8. PubMed ID: 10499742 [TBL] [Abstract][Full Text] [Related]
76. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding. Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025 [TBL] [Abstract][Full Text] [Related]
77. Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin. Flowers CE; Wilborn WH; Hyde BM Obstet Gynecol; 1983 Feb; 61(2):135-43. PubMed ID: 6296742 [TBL] [Abstract][Full Text] [Related]
78. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial. Yamaguti EM; Brito MB; Ferriani RA; Garcia AA; Rosa-e-Silva JC; Vieira CS Thromb Res; 2014 Dec; 134(6):1193-7. PubMed ID: 25283586 [TBL] [Abstract][Full Text] [Related]
79. 36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty. Lee PA; Klein K; Mauras N; Lev-Vaisler T; Bacher P J Clin Endocrinol Metab; 2014 Sep; 99(9):3153-9. PubMed ID: 24926950 [TBL] [Abstract][Full Text] [Related]
80. [Add back therapy for patients with endometriosis]. Aisaka K Nihon Rinsho; 2001 Jan; 59 Suppl 1():129-32. PubMed ID: 11235150 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]